Trials in Combination Therapy for CLL - Phase 2 Trial results with Obinutuzumab, Ibrutunib, & Venetoclax

Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the trials in combination therapy for Chronic Lymphoc... Author: moasc Added: 02/01/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts